T cell metabolism could be manipulated using genetic engineering,38 as PRODH2 overexpression can shift cells to an OXPHOS-based metabolism with more active mitochondria and an increased percentage of CD45RA+/CD62L− T cells post-tumor challenge.38 This evidence concerns the gene SELL and neoplasm.